Study assesses the efficacy of Rezum water vapor therapy in treating BPH
In this video, Dean Elterman, MD, MSc, FRCSC, discusses the background, findings, and takeaways of the study, “Rezūm water vapor therapy for large volume (≥80 mL) benign prostatic enlargement: large, multi-center cohort,” presented at the 2021 American Urological Association annual meeting. Elterman is an associate professor of urology at the University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.
